{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T01:10:12Z","timestamp":1778202612588,"version":"3.51.4"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.urolonc.2026.111082","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T03:39:10Z","timestamp":1775187550000},"page":"161-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Postchemotherapy orchiectomy in metastatic testicular germ cell tumors: Pathologic findings and predictors of residual viable disease"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9119-8048","authenticated-orcid":false,"given":"Ahmad","family":"Mousa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Amiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn","family":"Anson-Cartwright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eshetu G.","family":"Atenafu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Bedard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di Maria","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Glicksman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Padraig","family":"Warde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"O\u2019Malley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Prendeville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2026.111082_bib0001","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1245\/ASO.2005.01.013","article-title":"Germ cell tumors of the testis","volume":"12","author":"Carver","year":"2005","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.urolonc.2026.111082_bib0002","series-title":"American cancer society. Cancer facts & figs. 2017","year":"2017"},{"key":"10.1016\/j.urolonc.2026.111082_bib0003","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0022-5347(01)66355-9","article-title":"Delayed orchiectomy after chemotherapy for metastatic nonseminomatous germ cell tumors","volume":"155","author":"Leibovitch","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2026.111082_bib0004","first-page":"28","article-title":"Is the testis a chemo-privileged site? Is there a blood-testis barrier?","volume":"9","author":"Dave","year":"2007","journal-title":"Rev Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2026.111082_bib0005","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5489\/cuaj.7945","article-title":"Canadian Urological Association consensus guideline: management of testicular germ cell cancer","volume":"16","author":"Hamilton","year":"2022","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.urolonc.2026.111082_bib0006","doi-asserted-by":"crossref","first-page":"E152","DOI":"10.1111\/j.1464-410X.2012.11537.x","article-title":"Pathological findings after primary chemotherapy in patients undergoing simultaneous orchidectomy and retroperitoneal lymph node dissection for advanced germ cell tumours","volume":"111","author":"Miller","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2026.111082_bib0007","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1200\/JCO.1984.2.9.1025","article-title":"Pathologic findings at orchiectomy following chemotherapy for disseminated testicular cancer","volume":"2","author":"Greist","year":"1984","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2026.111082_bib0008","first-page":"407","article-title":"Role of chemotherapy prior to orchiectomy in metastatic testicular cancer\u2014Is testis really a sanctuary site?","volume":"8","author":"Reddy","year":"2014","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.urolonc.2026.111082_bib0009","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1034\/j.1600-0463.2003.11101121.x","article-title":"Testis conserving chemotherapy in germ cell cancer: its potential to increase understanding of the biology and treatment of carcinoma-in-situ","volume":"111","author":"Oliver","year":"2003","journal-title":"APMIS"},{"key":"10.1016\/j.urolonc.2026.111082_bib0010","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.urolonc.2015.01.014","article-title":"Hypogonadism and fertility issues following primary treatment for testicular cancer","volume":"33","author":"Oldenburg","year":"2015","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2026.111082_bib0011","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/pon.1772","article-title":"Perceptions of masculinity and self-image in adolescent and young adult testicular cancer survivors: implications for romantic and sexual relationships","volume":"20","author":"Carpentier","year":"2011","journal-title":"Psychooncology"},{"key":"10.1016\/j.urolonc.2026.111082_bib0012","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.euros.2025.07.004","article-title":"Pathologic and oncologic outcomes of patients undergoing orchiectomy after chemotherapy for advanced testicular germ cell tumors","volume":"79","author":"Jayalath","year":"2025","journal-title":"Eur Urol Open Sci"},{"issue":"5","key":"10.1016\/j.urolonc.2026.111082_bib0013","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1007\/s00120-014-3487-3","article-title":"Complications associated with inguinal orchiectomy and scrotal orchiectomy","volume":"53","author":"Anheuser","year":"2014","journal-title":"Urologe A"},{"key":"10.1016\/j.urolonc.2026.111082_bib0014","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1464-410X.1995.tb07678.x","article-title":"Ultrasonographic evaluation and clinical correlation of intratesticular lesions: a series of 39 cases","volume":"76","author":"Coret","year":"1995","journal-title":"Br J Urol"},{"key":"10.1016\/j.urolonc.2026.111082_bib0015","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/annonc\/mdt425","article-title":"A meta-analysis of patient outcomes with subcentimeter disease after chemotherapy for metastatic non-seminomatous germ cell tumor","volume":"25","author":"Ravi","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.urolonc.2026.111082_bib0016","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1200\/JCO.2009.23.0714","article-title":"Long-term follow-up of cisplatin combination chemotherapy in patients with disseminated nonseminomatous germ cell tumors: is a postchemotherapy retroperitoneal lymph node dissection needed after complete remission?","volume":"28","author":"Ehrlich","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2026.111082_bib0017","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.juro.2014.08.081","article-title":"Rates of teratoma and viable cancer at post-chemotherapy retroperitoneal lymph node dissection after induction chemotherapy for good-risk nonseminomatous germ cell tumors","volume":"193","author":"Kundu","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2026.111082_bib0018","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nrurol.2010.100","article-title":"Organ-sparing approaches for testicular masses","volume":"7","author":"Zuniga","year":"2010","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.urolonc.2026.111082_bib0019","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.eururo.2010.01.014","article-title":"Organ-sparing surgery for adult testicular tumours: a systematic review of the literature","volume":"57","author":"Giannarini","year":"2010","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2026.111082_bib0020","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.juro.2018.02.068","article-title":"Serum miRNA predicts viable disease after chemotherapy in patients with testicular nonseminomatous germ cell tumor","volume":"200","author":"Le\u00e3o","year":"2018","journal-title":"J Urol"},{"issue":"16","key":"10.1016\/j.urolonc.2026.111082_bib0021","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1200\/JCO.18.01480","article-title":"Serum levels of microRNA-371a-3p (M371 test) as a new biomarker of testicular germ cell tumors: results of a prospective multicentric study","volume":"37","author":"Dieckmann","year":"2019","journal-title":"J Clin Oncol"},{"issue":"16 Suppl","key":"10.1016\/j.urolonc.2026.111082_bib0022","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1200\/JCO.2024.42.16_suppl.5034","article-title":"Circulating tumor DNA as a biomarker for minimal residual disease detection in testicular germ cell tumors","volume":"42","author":"Hassoun","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2026.111082_bib0023","article-title":"Utility of tumor-informed circulating tumor DNA analysis in the surveillance of nonseminomatous germ cell tumors","author":"Ben-David","year":"2024","journal-title":"Urol Oncol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926000931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926000931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:29:31Z","timestamp":1778200171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143926000931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1078143926000931"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.111082","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Postchemotherapy orchiectomy in metastatic testicular germ cell tumors: Pathologic findings and predictors of residual viable disease","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.111082","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}